Source: Virtual Congress 2020 – Translational science in respiratory infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Nishimoto (Funabashi, Japan), G. Kimura (Funabashi, Japan), T. Nakaoki (Funabashi, Japan), P. Strong (London, United Kingdom), K. Ito (London, United Kingdom), Y. Kizawa (Funabashi, Japan). Effects of PC945, a novel antifungal agent optimised for lung delivery, on Candida albicans lung infection in mice. 2321

Member's Comments

No comment yet.

Related content which might interest you: PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Therapeutic intratracheal phage application against Acinetobacter baumannii lung infection in mice Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Multifocal colonization and hydrolytic activity of candida strains isolated from lung cancer patients (LC) Source: Eur Respir J 2001; 18: Suppl. 33, 304s Year: 2001 The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by P. aeruginosa Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa Source: Eur Respir J, 55 (3) 1802456; 10.1183/13993003.02456-2018 Year: 2020 Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model Source: Eur Respir J 2007; 29: 965-968 Year: 2007 Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Three-dimensional lung epithelial cells potentiate aminoglycoside efficacy by enhancing intracellular pH in Pseudomonas aeruginosa Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis}, Source: Eur Respir J 2012; 40: 1014-1023 Year: 2012 Comparison between two protocols of preventing treatment of chronic Pseudomonas aeruginosa (Pa) infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Assessing the synergistic effect of the enhancer compound HT61 on Tobramycin activity in a murine model of pulmonary infection Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017 Xylitol affects production of virulence factors and biofilm in pseudomonas aeruginosa; effects on respiratory epithelium inflammation. "In vitro" studies Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Strict antifungal prophylaxis reduces the risk of invasive fungal infections after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 777s Year: 2006 Antibiotics reduce dual pathogen isolates more than single pathogen isolates following COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021